Paper39985508
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis.
Shah T and 19 others. JACC Cardiovasc Interv, 2025. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis. Papers, record 39985508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39985508
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Aortic Valve Stenosis | Major topic |
| Aortic Valve | Major topic |
| Humans | |
| Male | |
| Disease Progression | |
| Female | |
| Retrospective Studies | |
| Aged | |
| Time Factors | |
| Treatment Outcome | |
| Risk Factors | |
| Severity of Illness Index | |
| Aged, 80 and over | |
| Middle Aged | |
| Risk Assessment | |
| Electronic Health Records |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42977773 | Cardiovascular disease in diabetes mellitus: beyond atherosclerosis and heart failure. | Nat Rev Endocrinol | 2026 | https://conductscience.org/library/papers/42977773 | PubMed |
| 42955596 | Effects of SGLT2 inhibition on cardiac remodeling and heart failure development in aortic stenosis rats. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42955596 | PubMed |
| 42936081 | Clinical Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors After Transcatheter Aortic Valve Replacement in Patients With Diabetes: A Global Retrospective Study. | J Soc Cardiovasc Angiogr Interv | 2026 | https://conductscience.org/library/papers/42936081 | PubMed |
| 42769931 | Sodium-Glucose Cotransporter-2 Inhibitors in Valvular Heart Disease: From Mechanistic Insights to Clinical Application. | J Soc Cardiovasc Angiogr Interv | 2026 | https://conductscience.org/library/papers/42769931 | PubMed |
| 42652758 | Sodium-Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps-A Structured Narrative Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/42652758 | PubMed |
| 42284627 | Emerging Role of Sodium-Glucose Cotransporter-2 Inhibitors in Aortic Stenosis. | JACC Basic Transl Sci | 2026 | https://conductscience.org/library/papers/42284627 | PubMed |
| 42233563 | SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease. | JACC Asia | 2026 | https://conductscience.org/library/papers/42233563 | PubMed |
| 42136720 | Differential expression of GLP1R, PCSK9, and SGLT2 in human aortic versus mitral valve tissues: exploratory findings in calcific aortic valve disease. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42136720 | PubMed |
| 41938341 | Characteristics, clinical outcomes and molecular mechanisms associated with severe diastolic dysfunction in aortic stenosis. | J Mol Cell Cardiol Plus | 2026 | https://conductscience.org/library/papers/41938341 | PubMed |
| 41906747 | Heart failure and tricuspid regurgitation: the role of SGLT2 inhibitors in improving outcomes. | Eur Heart J Cardiovasc Pharmacother | 2026 | https://conductscience.org/library/papers/41906747 | PubMed |
| 41746781 | Efficacy of SGLT2 Inhibitors on Clinical Outcomes After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. | Endocrinol Diabetes Metab | 2026 | https://conductscience.org/library/papers/41746781 | PubMed |
| 41711713 | Interplay between medical and interventional therapies in valvular heart disease and heart failure: an expert opinion paper. | ESC Heart Fail | 2026 | https://conductscience.org/library/papers/41711713 | PubMed |
| 41598653 | Assessing Potential Valve-Preserving Effects of SGLT2 Inhibitors in Degenerative Aortic Stenosis: A Propensity-Matched Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41598653 | PubMed |
| 41595617 | Next-Generation SGLT2 Inhibitors: Innovations and Clinical Perspectives. | Biomedicines | 2025 | https://conductscience.org/library/papers/41595617 | PubMed |
| 41545296 | Prognostic significance implications of aortic valve sclerosis in the development of aortic stenosis: a systematic review and meta-analysis. | Open Heart | 2026 | https://conductscience.org/library/papers/41545296 | PubMed |
| 41294151 | Human Plasma in Calcific Aortic Valve Disease: Not Simply a Depot of Biomarkers. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/41294151 | PubMed |
| 41294140 | Detrimental Effect of Plasma From Patients With Severe Aortic Stenosis on Valvular Endothelial Cells: Role of Proinflammatory Cytokines and Factor Xa. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/41294140 | PubMed |
| 41096081 | Association of SGLT2 Inhibitors with Mortality and Bioprosthesis Valve Failure After TAVR: A Propensity-Matched Cohort Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/41096081 | PubMed |
| 41055791 | The use of SGLT2 inhibitors in older people: What is important? | Aging Clin Exp Res | 2025 | https://conductscience.org/library/papers/41055791 | PubMed |
| 40839906 | Subclinical Leaflet Thrombosis and Subclinical Aortic Valve Complex Thrombosis in TAVR. | JACC Adv | 2025 | https://conductscience.org/library/papers/40839906 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39985508
GET https://conductscience.org/api/papers/v1/39985508/cited_by?page=2